MoonLake Immunotherapeutics (MLTX) Sector
Health Care

(Current) $45.70
-0.93 (-1.99%) Open Price: 37.82

MoonLake Immunotherapeutics is a clinical-stage biopharmaceutical company unlocking the potential of Sonelokimab, the novel investigational Nanobody® for the treatment of inflammation, to revolutionize outcomes for patients

(03/13/25) $37.82
(01/27/25) $46.63
(01/27/25) (Qty.)423,168
(03/13/25) $37.73
(03/13/25) $39.44
(03/09/25) $36.52
(12/15/24) $58.26
Stocktwits
LetsEncrypt SSL Secure Stripe Payment Processing